DURHAM, N.C.--(EON: Enhanced Online News)--Patheon N.V. (NYSE:PTHN), a leading global provider of pharmaceutical development and manufacturing services, today announced that it will release financial results for the fourth quarter and fiscal year ended October 31, 2016 on Tuesday, December 20, 2016. In addition, the company will provide its outlook for fiscal 2017.
Patheon’s management – Jim Mullen, CEO; Michel Lagarde, President; and Stuart Grant, CFO will host a conference call and webcast to discuss the results on Tuesday, December 20, 2016 at 8:00 a.m. Eastern Standard Time (EST). The conference call webcast can be accessed through the investor relations section of Patheon’s website, www.patheon.com/. To participate in the conference call, dial 1-877-407-9039 (USA) or 1-201-689-8470 (International). A replay of the webcast will be available on the company's website for 90 days.
Patheon is a leading global provider of pharmaceutical development and manufacturing services. With approximately 8,000 employees worldwide, Patheon provides a comprehensive, integrated and highly customizable set of solutions to help customers of all sizes satisfy complex development and manufacturing needs at any stage of the pharmaceutical development cycle.